News

Invivyd, SPEAR Study Group to assess the effects of monoclonal antibody therapy for recent Covid & Covid-19 post-vaccination syndrome: Waltham, Massachusetts Saturday, July 5, 202 ...
Onward Medical submits two major regulatory applications for its ARC-EX system; seeking clearance to expand its indication for home use: Eindhoven, the Netherlands Saturday, July ...
Kairali Ayurvedic Group opens first Ayurveda wellness centre in Jaipur: Our Bureau, Mumbai Saturday, July 5, 2025, 11:30 Hrs [IST] Kairali Ayurvedic Group, one of India’s most t ...
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China: Beijing Saturday, July 5, 2025, 11:00 Hrs [IST] InnoCare Pharma, a commercial ...
HanchorBio inks licensing pact with Shanghai Henlius Biotech to develop & commercialise HCB101 across Greater China: Taipei, Shanghai Saturday, July 5, 2025, 10:00 Hrs [IST] Hanch ...
AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...
DCC recommends DCGI to share SOPs and formats with States as per IDP: Gireesh Babu, New Delhi Saturday, July 5, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee (DCC) has re ...
Indian healthcare sector grapples with acute shortages of infrastructure & skilled professionals: Dr Raj Nagarkar: Nandita Vijayasimha, Bengaluru Saturday, July 5, 2025, 08:00 Hrs ...
The Union government's substantial and commendable support for the Indian pharmaceutical industry, particularly for the MSME sector, is evident. T. Revichandran, vice-president of IDMA South Region, ...
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has reported that India's pharmaceutical export continued its growth trajectory with USD 2,475.70 million in May 2025, cumulating to ...
CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab: Vancouver, Washington Friday, July 4, ...